or Try an Advanced Search...

    Technical Analysis for SRZN - Surrozen, Inc.

    Grade Last Price % Change Price Change
    B 10.70 -2.28% -0.25
    SRZN closed down 2.28 percent on Monday, July 1, 2024, on 13 percent of normal volume. It was able to find support at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical SRZN trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    50 DMA Support Bullish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Multiple of Ten Bullish Other 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Crossed Above 20 DMA Bullish -2.28%
    Crossed Above 50 DMA Bullish -2.28%
    Expansion Pivot Buy Setup Bullish Swing Setup -2.28%
    Multiple of Ten Bullish Other -2.28%
    Gapped Down Weakness -2.28%
    Older End-of-Day Signals for SRZN ...

       Recent Intraday Alerts

    Alert Time
    Down 3% 3 days ago
    Fell Below Lower Bollinger Band 3 days ago
    Down 2 % 3 days ago
    Down 1% 3 days ago
    Down 5% 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SRZN Chart by TradingView
    Basic chart:

    Profile

    Surrozen, Inc., a biopharmaceutical company, develops targeted regenerative antibodies to repair a range of tissues and organs damaged by serious disease, and to improve organ function. The company provides antibody platforms that functions as Wnt and R-spondin mimetics in stimulating cell and organ-specific tissue regeneration. Its programs include SZN-043, a liver-specific R-spondin-mimetic to stimulate hepatocyte regeneration in acute and chronic liver disease; and SZN-1326, an intestine-specific Wnt-mimetic to repair diseased epithelial tissue and address an unmet need in patients with inflammatory bowel disease. Surrozen, Inc. was incorporated in 2015 and is based in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Immunology Antibodies Antibody Inflammatory Bowel Disease Glycoproteins Organs Senescence Gastrointestinal Tract Liver

    Is SRZN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
    Jun 10 Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
    Jun 4 Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
    May 9 Surrozen Non-GAAP EPS of -$4.24
    May 9 Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
    May 8 Surrozen Provides First Quarter 2024 Financial Results and Business Update
    Apr 18 Surrozen files to sell 1.09M shares of common stock for holders
    Apr 1 Surrozen announces up to $192.5M private placement of securities priced at-the-market under Nasdaq rules
    Apr 1 Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
    Apr 1 Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
    See more SRZN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.19
    52 Week Low 4.5
    Average Volume 9,300
    200-Day Moving Average 9.34
    50-Day Moving Average 10.30
    20-Day Moving Average 10.74
    10-Day Moving Average 10.33
    Average True Range 0.84
    RSI (14) 51.46
    ADX 22.33
    +DI 18.64
    -DI 28.47
    Chandelier Exit (Long, 3 ATRs) 9.47
    Chandelier Exit (Short, 3 ATRs) 11.70
    Upper Bollinger Bands 11.84
    Lower Bollinger Band 9.64
    Percent B (%b) 0.48
    BandWidth 20.43
    MACD Line -0.05
    MACD Signal Line -0.02
    MACD Histogram -0.0262
    Fundamentals Value
    Market Cap 21.81 Million
    Num Shares 2.04 Million
    EPS -17.40
    Price-to-Earnings (P/E) Ratio -0.61
    Price-to-Sales 1.43
    Price-to-Book 0.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.74
    Resistance 3 (R3) 12.61 11.81 12.40
    Resistance 2 (R2) 11.81 11.29 11.87 12.29
    Resistance 1 (R1) 11.25 10.97 10.85 11.38 12.17
    Pivot Point 10.45 10.45 10.25 10.51 10.45
    Support 1 (S1) 9.89 9.93 9.49 10.02 9.23
    Support 2 (S2) 9.09 9.61 9.15 9.11
    Support 3 (S3) 8.53 9.09 9.00
    Support 4 (S4) 8.66